I cannot share specifics. Based on the information
Post# of 36537
(Total Views: 377)
Posted On: 04/20/2019 8:06:32 AM
I cannot share specifics. Based on the information I have been given during my MSO introduction call, there are providers in the MSO. Enough that should they continue to grow the MSO with new providers/states coming onboard and add new lines of profitable service, things should work out.
I have seen at least 20 medication formularies from various pharmicies doing this kind business. The one I have reviewed from NDS is more robust than most.
I sure would like Joe to give us an update of his thoughts vs what he provided 3 months ago in the Wall Street interview:
Generex Biotechnology Corp. (OTC: GNBT): Building a billion dollar next-generation healthcare business. Eighteen months was the expected timeframe, if I recall correctly.
I have seen at least 20 medication formularies from various pharmicies doing this kind business. The one I have reviewed from NDS is more robust than most.
I sure would like Joe to give us an update of his thoughts vs what he provided 3 months ago in the Wall Street interview:
Generex Biotechnology Corp. (OTC: GNBT): Building a billion dollar next-generation healthcare business. Eighteen months was the expected timeframe, if I recall correctly.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼